Selection of purine nucleoside analogs based on multiple biological and biochemical parameters.
D000255:Adenosine Triphosphate / Q000378:metabolism; D002478:Cells, Cultured / Q000187:drug effects; D003570:Cytidine Triphosphate / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D005561:Formates / Q000378:metabolism; D006157:Guanosine Monophosphate / Q000378:metabolism; D006160:Guanosine Triphosphate / Q000378:metabolism; D006801:Humans; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000378:metabolism; D007291:Inosine Monophosphate / Q000378:metabolism; D010766:Phosphorylation; D011684:Purine Nucleosides / Q000494:pharmacology*; D012313:RNA / Q000096:biosynthesis; D013936:Thymidine / Q000378:metabolism; D014529:Uridine / Q000378:metabolism; D014544:Uridine Triphosphate / Q000378:metabolism
D005561:Formates; D007042:Hypoxanthines; D011684:Purine Nucleosides; D007291:Inosine Monophosphate; D019271:Hypoxanthine; D012313:RNA; D003570:Cytidine Triphosphate; D006157:Guanosine Monophosphate; D006160:Guanosine Triphosphate; D000255:Adenosine Triphosphate; D004247:DNA; D014544:Uridine Triphosphate; D013936:Thymidine; D014529:Uridine